These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34228639)

  • 21. Intraneuronal APP and extracellular Aβ independently cause dendritic spine pathology in transgenic mouse models of Alzheimer's disease.
    Zou C; Montagna E; Shi Y; Peters F; Blazquez-Llorca L; Shi S; Filser S; Dorostkar MM; Herms J
    Acta Neuropathol; 2015 Jun; 129(6):909-20. PubMed ID: 25862638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. α(2A) adrenergic receptor promotes amyloidogenesis through disrupting APP-SorLA interaction.
    Chen Y; Peng Y; Che P; Gannon M; Liu Y; Li L; Bu G; van Groen T; Jiao K; Wang Q
    Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17296-301. PubMed ID: 25404298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emergence of synaptic and cognitive impairment in a mature-onset APP mouse model of Alzheimer's disease.
    Sri S; Pegasiou CM; Cave CA; Hough K; Wood N; Gomez-Nicola D; Deinhardt K; Bannerman D; Perry VH; Vargas-Caballero M
    Acta Neuropathol Commun; 2019 Feb; 7(1):25. PubMed ID: 30795807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From synaptic spines to nuclear signaling: nuclear and synaptic actions of the amyloid precursor protein.
    Octave JN; Pierrot N; Ferao Santos S; Nalivaeva NN; Turner AJ
    J Neurochem; 2013 Jul; 126(2):183-90. PubMed ID: 23495999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
    McClean PL; Hölscher C
    Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD8
    Unger MS; Li E; Scharnagl L; Poupardin R; Altendorfer B; Mrowetz H; Hutter-Paier B; Weiger TM; Heneka MT; Attems J; Aigner L
    Brain Behav Immun; 2020 Oct; 89():67-86. PubMed ID: 32479993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. APP depletion alters selective pre- and post-synaptic proteins.
    Martinsson I; Capetillo-Zarate E; Faideau M; Willén K; Esteras N; Frykman S; Tjernberg LO; Gouras GK
    Mol Cell Neurosci; 2019 Mar; 95():86-95. PubMed ID: 30763689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reverting Metabolic Dysfunction in Cortex and Cerebellum of APP/PS1 Mice, a Model for Alzheimer's Disease by Pioglitazone, a Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Agonist.
    Chang KL; Wong LR; Pee HN; Yang S; Ho PC
    Mol Neurobiol; 2019 Nov; 56(11):7267-7283. PubMed ID: 31016475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Qingyangshen mitigates amyloid-β and Tau aggregate defects involving PPARα-TFEB activation in transgenic mice of Alzheimer's disease.
    Iyaswamy A; Krishnamoorthi SK; Zhang H; Sreenivasmurthy SG; Zhu Z; Liu J; Su CF; Guan XJ; Wang ZY; Cheung KH; Song JX; Durairajan SSK; Li M
    Phytomedicine; 2021 Oct; 91():153648. PubMed ID: 34332287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Aβ Oligomers on Neuronal APP Triggers a Vicious Cycle Leading to the Propagation of Synaptic Plasticity Alterations to Healthy Neurons.
    Rolland M; Powell R; Jacquier-Sarlin M; Boisseau S; Reynaud-Dulaurier R; Martinez-Hernandez J; André L; Borel E; Buisson A; Lanté F
    J Neurosci; 2020 Jul; 40(27):5161-5176. PubMed ID: 32444385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease.
    Manczak M; Kandimalla R; Fry D; Sesaki H; Reddy PH
    Hum Mol Genet; 2016 Dec; 25(23):5148-5166. PubMed ID: 27677309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Artesunate restores the levels of inhibitory synapse proteins and reduces amyloid-β and C-terminal fragments (CTFs) of the amyloid precursor protein in an AD-mouse model.
    Kiss E; Kins S; Zöller Y; Schilling S; Gorgas K; Groß D; Schlicksupp A; Rosner R; Kirsch J; Kuhse J
    Mol Cell Neurosci; 2021 Jun; 113():103624. PubMed ID: 33933588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylene blue modulates β-secretase, reverses cerebral amyloidosis, and improves cognition in transgenic mice.
    Mori T; Koyama N; Segawa T; Maeda M; Maruyama N; Kinoshita N; Hou H; Tan J; Town T
    J Biol Chem; 2014 Oct; 289(44):30303-30317. PubMed ID: 25157105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acetylcholinesterase is increased in the brains of transgenic mice expressing the C-terminal fragment (CT100) of the beta-amyloid protein precursor of Alzheimer's disease.
    Sberna G; Sáez-Valero J; Li QX; Czech C; Beyreuther K; Masters CL; McLean CA; Small DH
    J Neurochem; 1998 Aug; 71(2):723-31. PubMed ID: 9681463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ryanodine receptor blockade reduces amyloid-β load and memory impairments in Tg2576 mouse model of Alzheimer disease.
    Oulès B; Del Prete D; Greco B; Zhang X; Lauritzen I; Sevalle J; Moreno S; Paterlini-Bréchot P; Trebak M; Checler F; Benfenati F; Chami M
    J Neurosci; 2012 Aug; 32(34):11820-34. PubMed ID: 22915123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ca
    Yu Z; Dou F; Wang Y; Hou L; Chen H
    J Neuroinflammation; 2018 Nov; 15(1):316. PubMed ID: 30442153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BHBA treatment improves cognitive function by targeting pleiotropic mechanisms in transgenic mouse model of Alzheimer's disease.
    Wu Y; Gong Y; Luan Y; Li Y; Liu J; Yue Z; Yuan B; Sun J; Xie C; Li L; Zhen J; Jin X; Zheng Y; Wang X; Xie L; Wang W
    FASEB J; 2020 Jan; 34(1):1412-1429. PubMed ID: 31914599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cryptotanshinone, a compound from Salvia miltiorrhiza modulates amyloid precursor protein metabolism and attenuates beta-amyloid deposition through upregulating alpha-secretase in vivo and in vitro.
    Mei Z; Zhang F; Tao L; Zheng W; Cao Y; Wang Z; Tang S; Le K; Chen S; Pi R; Liu P
    Neurosci Lett; 2009 Mar; 452(2):90-5. PubMed ID: 19154776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.